Analyst Ratings for Achillion Pharmaceuticals (ACHN)

ACHN Rating Summary

ACHN Price Target Summary

  |   Expand Research on ACHN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $15.13 (+100.3%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/4/2013 Baird New Coverage Outperform
(N/A)
17.00
(N/A)
8.76 7.55 -13.81% Details
9/19/2012 Deutsche Bank
» Updated 10/16/2012
New Coverage Buy
(N/A)
17.00
(12.00)
8.10 7.55 -6.79% Details
9/19/2012 BofA/Merrill Lynch Upgrade Buy
(Underperform)
N/A
(N/A)
8.10 7.55 -6.79% Details
8/16/2012 JMP Securities Upgrade Market Outperform
(Market Perform)
10.00
(N/A)
5.90 7.55 27.97% Details
6/13/2012 Maxim Group New Coverage Buy
(N/A)
12.00
(N/A)
6.16 7.55 22.56% Details
5/7/2012 UBS Upgrade Neutral
(N/A)
N/A
(N/A)
5.99 7.55 26.04% Details
4/17/2012 Credit Suisse New Coverage Outperform
(N/A)
N/A
(N/A)
8.77 7.55 -13.91% Details
3/27/2012 Wedbush New Coverage Outperform
(N/A)
13.00
(N/A)
10.22 7.55 -26.13% Details
11/29/2011 Wells Fargo
» Updated 11/12/2012
New Coverage Outperform
(N/A)
N/A
(N/A)
5.95 7.55 26.89% Details
9/8/2011 Piper Jaffray New Coverage Overweight
(N/A)
12.00
(N/A)
5.72 7.55 31.99% Details
6/2/2011 Brean Capital
» Updated 4/23/2012
New Coverage Buy
(N/A)
20.00
(N/A)
7.39 7.55 2.17% Details
6/2/2011 ThinkEquity
» Updated 1/10/2012
New Coverage Buy
(N/A)
20.00
(N/A)
7.39 7.55 2.17% Details
5/26/2011 William Blair New Coverage Outperform
(N/A)
N/A
(N/A)
6.09 7.55 23.97% Details
5/12/2011 Roth Capital New Coverage Buy
(N/A)
N/A
(N/A)
5.10 7.55 48.04% Details
3/1/2011 Leerink Swann New Coverage Outperform
(N/A)
N/A
(N/A)
5.85 7.55 29.06% Details
Like ACHN Ratings? Also take a look at GILD, IDIX, VRTX, ABT

ACHN Ratings News